Bivamelagon

N/A

Report date: 2025/05/15 11:45:53
NME

Base Information

Drug NameBivamelagon
Drug Alias NameLB-54640LR-19021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 4 agonists
TargetsMelanocortin receptor 4
Therapy Area/IndicationsHypothalamic ObesityOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypothalamic ObesityOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A